Zobrazeno 1 - 10 of 1 833 pro vyhledávání: '"Laux V"'
1
Akademický článek
Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection
Autor: Becker A, Röhrich K, Leske A, Heinicke U, Knape T, Kannt A, Trümper V, Sohn K, Wilken-Schmitz A, Neb H, Adam EH, Laux V, Parnham MJ, Onasch V, Weigert A, Zacharowski K, von Knethen A
Publikováno v: ImmunoTargets and Therapy, Vol Volume 13, Pp 595-616 (2024)
Antonia Becker,1 Karoline Röhrich,1 Amanda Leske,1 Ulrike Heinicke,1 Tilo Knape,2 Aimo Kannt,2,3 Verena Trümper,4 Kai Sohn,5 Annett Wilken-Schmitz,1 Holger Neb,1 Elisabeth H Adam,1 Volker Laux,2 Michael J Parnham,2 Valerie Onasch,4 Andreas Weigert,
Externí odkaz: https://doaj.org/article/deb4c474a3804763b80e9aa908eb6669
Zobrazit plný text záznamu
2
Akademický článek
Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of T h 2 Cells as Therapeutic Concept in COVID-19 Infection.
Autor: Becker A; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany., Röhrich K; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany., Leske A; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany., Heinicke U; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany., Knape T; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, 60596, Germany., Kannt A; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, 60596, Germany.; Institute of Clinical Pharmacology, Goethe University, Frankfurt, 60590, Germany., Trümper V; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, 60590, Germany., Sohn K; Innovation Field in-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, 70569, Germany., Wilken-Schmitz A; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany., Neb H; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany., Adam EH; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany., Laux V; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, 60596, Germany., Parnham MJ; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, 60596, Germany., Onasch V; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, 60590, Germany., Weigert A; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, 60590, Germany., Zacharowski K; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, 60596, Germany., von Knethen A; Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany.
Publikováno v: ImmunoTargets and therapy [Immunotargets Ther] 2024 Nov 02; Vol. 13, pp. 595-616. Date of Electronic Publication: 2024 Nov 02 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units.
Autor: Kugler S; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS, Schloss Birlinghoven 1, St. Augustin, Germany., Hahnefeld L; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany. Electronic address: lisa.hahnefeld@itmp.fraunhofer.de., Kloka JA; Goethe University Frankfurt, University Hospital, Clinic for Anesthesiology, Intensive Care Medicine and Pain Therapy, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany., Ginzel S; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS, Schloss Birlinghoven 1, St. Augustin, Germany., Nürenberg-Goloub E; Goethe University Frankfurt, University Hospital, Clinic for Anesthesiology, Intensive Care Medicine and Pain Therapy, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany., Zinn S; Goethe University Frankfurt, University Hospital, Clinic for Anesthesiology, Intensive Care Medicine and Pain Therapy, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany; Fraunhofer Leistungszentrum TheraNova, Theodor-Stern-Kai 6, 60596, Frankfurt am Main, Germany., Vehreschild MJ; Goethe University Frankfurt, University Hospital, Department of Internal Medicine, Infectious Diseases, 60590, Frankfurt am Main, Germany., Zacharowski K; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Goethe University Frankfurt, University Hospital, Clinic for Anesthesiology, Intensive Care Medicine and Pain Therapy, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany., Lindau S; Goethe University Frankfurt, University Hospital, Clinic for Anesthesiology, Intensive Care Medicine and Pain Therapy, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany., Ullrich E; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany; Goethe University Frankfurt, Department of Pediatrics, Experimental Immunology and Cell Therapy, Frankfurt, Germany., Burmeister J; Fraunhofer Institute for Computer Graphics Research IGD, Darmstadt, Germany., Kohlhammer J; Fraunhofer Institute for Computer Graphics Research IGD, Darmstadt, Germany., Schwäble J; Goethe University Frankfurt, University Hospital, Institute of Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg, Frankfurt, Germany., Gurke R; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany., Dorochow E; Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany., Bennett A; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany., Dauth S; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany., Campe J; Goethe University Frankfurt, Department of Pediatrics, Experimental Immunology and Cell Therapy, Frankfurt, Germany; Goethe University Frankfurt, Biological Sciences, Frankfurt am Main, Germany., Knape T; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany., Laux V; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany., Kannt A; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Leistungszentrum TheraNova, Theodor-Stern-Kai 6, 60596, Frankfurt am Main, Germany., Köhm M; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Goethe University Frankfurt, University Hospital, Rheumatology, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany., Geisslinger G; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany., Resch E; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany., Behrens F; Fraunhofer Cluster of Excellence Immune Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany; Goethe University Frankfurt, University Hospital, Rheumatology, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany.
Publikováno v: Talanta [Talanta] 2024 Feb 01; Vol. 268 (Pt 1), pp. 125295. Date of Electronic Publication: 2023 Oct 09.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Developing advanced models of biological membranes with hydrogenous and deuterated natural glycerophospholipid mixtures.
Autor: Corucci G; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France; École doctorale de Physique, Université Grenoble Alpes, 38400 Saint-Martin-d'Héres, France., Batchu KC; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France., Luchini A; European Spallation Source ERIC, P.O. Box 176, SE-221 00 Lund, Sweden; Department of Physics and Geology, University of Perugia, Via Alessandro Pascoli, 06123 Perugia, Italy., Santamaria A; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France; Departamento de Química Física, Universidad Complutense de Madrid, 28040 Madrid, Spain., Frewein MPK; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France; Institute of Molecular Biosciences, University of Graz, NAWI Graz, Graz, 8010, Austria., Laux V; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France., Haertlein M; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France., Yamaryo-Botté Y; ApicoLipid Team & GEMELI Lipidomics Platform, Institute for Advanced Biosciences, CNRS UMR5309, INSERM (-National Institute for Health and Medical Research) U1209, Université Grenoble Alpes, 38000 Grenoble, France., Botté CY; ApicoLipid Team & GEMELI Lipidomics Platform, Institute for Advanced Biosciences, CNRS UMR5309, INSERM (-National Institute for Health and Medical Research) U1209, Université Grenoble Alpes, 38000 Grenoble, France., Sheridan T; University College Dublin, Belfield, Dublin 4, Dublin, Ireland; AbbVie, Clonshaugh, Dublin 7, Co. Dublin, Ireland., Tully M; European Synchrotron Radiation Facility (ESRF), 71 avenue des Martyrs, CS 40220, 38043, Grenoble, France., Maestro A; Centro de Física de Materiales (CSIC, UPV/EHU) - Materials Physics Center MPC, Paseo Manuel de Lardizabal 5, E-20018 San Sebastián, Spain; IKERBASQUE - Basque Foundation for Science, Plaza Euskadi 5, E-48009 Bilbao, Spain., Martel A; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France., Porcar L; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France., Fragneto G; Institut Laue-Langevin, 71 avenue des Martyrs, CS 20156, 38042 Grenoble, France; École doctorale de Physique, Université Grenoble Alpes, 38400 Saint-Martin-d'Héres, France; European Spallation Source ERIC, P.O. Box 176, SE-221 00 Lund, Sweden. Electronic address: fragneto@ill.eu.
Publikováno v: Journal of colloid and interface science [J Colloid Interface Sci] 2023 Sep; Vol. 645, pp. 870-881. Date of Electronic Publication: 2023 May 05.
Zobrazit plný text záznamu
8
Strikingly Different Roles of SARS-CoV-2 Fusion Peptides Uncovered by Neutron Scattering
Autor: Santamaria, A., Batchu, K.C., Matsarskaia, O., Prévost, S.F., Russo, D., Natali, F., Seydel, T., Hoffmann, I., Laux, V., Haertlein, M., Darwish, T.A., Russell, R.A., Corucci, G., Fragneto, G., Maestro, A., Zaccai Nathan, R., Zaccai, N.R.
Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
'Journal of the American Chemical Society ', vol: 144, pages: 2968-2979 (2022)
Funder: National Collaborative Research Infrastructure Strategy (NCRIS)
Funder: ANR/NSF-PIRE
Funder: Science and Technology Facilities Council
Funder: Institut Laue Langevin
Coronavirus disease-2019 (COVID-19), a potentially letha
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb136b9ceab4611fec86cb3cd56e072
http://hdl.handle.net/10261/269305
Zobrazit plný text záznamu
9
Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment - From Mice to Men
Autor: Knethen, A. von, Heinicke, U., Laux, V., Parnham, M.J., Steinbicker, A.U., Zacharowski, K.
Acute respiratory distress syndrome (ARDS) is a major cause of patient mortality in intensive care units (ICUs) worldwide. Considering that no causative treatment but only symptomatic care is available, it is obvious that there is a high unmet medica
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______610::c27b42c8890c22bf86c1931e5fe1a65b
https://publica.fraunhofer.de/handle/publica/416196
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje